Skip to content
★ Sign in to follow
SM

Steven Morris

Creo Medical Group plc
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€177k
▼ Sales (0 ops.)
—

Latest filing published 23 Nov 2018 for Creo Medical Group plc, €59k.

Filing timeline

BuySale
Steven Morris

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Steven Morris: trading record in brief

This profile gathers the share dealings of Steven Morris in Creo Medical Group plc. Over a trading history stretching from 22 December 2017 to 22 November 2018, the count stands at 3 filings.

Purchases make up the whole of the open-market record (1 purchase, €177k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 option exercises. 2018 to date brings 1 purchase and no sales.

Most recently, on 23 November 2018, the filings show an option exercise worth €59k in Creo Medical Group plc. The clock since the last published purchase (9 January 2018) now reads 3,225 days. Publication is fast: at least half of the trades appear on RNS (LSE) on the same day. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Steven Morris

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◇
    Chief Operating OfficerExecutivesCreo Medical Group plc
    52,282 GBP19FCA-NSM
    336,000 shares@ £0.1556100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20181123104356_13878591_20200330111438130_7702
  • ▲
    Chief Operating OfficerExecutivesCreo Medical Group plc
    156,621 GBP0FCA-NSM
    230,325 shares@ £0.68London Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20180109174319_13490681_20200330111417429_20407
    Canonical exit: 9 Apr 2018 (T+90)
  • ◇
    Chief Operating OfficerExecutivesCreo Medical Group plc
    17,894 GBP0FCA-NSM
    115,000 shares@ £0.1556Off MarketISIN GB00BZ1BLL44FCA-NSM:LSE20171222121027_13476278_20200330131510628_19125

3 of 3 declarations